Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-5 of 5 for your search:
Start Over
Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes
Phase: Phase II
Type: Treatment
Status: Closed
Age: 10 and over
Sponsor: Other
Protocol IDs: 25145-CADEN, CADEN, NCT00953420
Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: NU 98H1, NCI-G00-1739, NCT00005606
Cell Bank of Epstein Barr Virus Specific Cytotoxic T Lymphocytes
Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 12 months to 75 years
Sponsor: Other
Protocol IDs: 04/7-M, NCT01823718
Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
Phase: Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 6676-ETNA, ETNA, NCT00058812
Start Over